629 results on '"Storer B"'
Search Results
2. The prevalence of anxiety disorders in dermatology outpatients: a systematic review and meta‐analysis
3. Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?
4. Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity
5. Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up
6. The association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation
7. Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
8. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation
9. Cutaneous macrophage infiltration in acute GvHD
10. Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
11. Immunomodulatory Effects of Mixed Hematopoietic Chimerism: Immune Tolerance in Canine Model of Lung Transplantation
12. Comorbidity burden in patients with chronic GVHD
13. Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center
14. The quality of life of adult survivors of childhood hematopoietic cell transplant
15. Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
16. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens
17. Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant
18. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis
19. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation
20. Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning
21. MIG: a plasma chronic GVHD biomarker that is diagnostic at onset and associated with disease severity: O324
22. Canine DLA-79 gene: an improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host disease
23. Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors
24. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience
25. Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights
26. Chronic Kidney Disease Following Non-Myeloablative Hematopoietic Cell Transplantation
27. Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning
28. DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs
29. Endothelin Levels Increase in Rat Focal and Global Ischemia
30. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
31. Softwire Hub and Spoke Deployment Framework with Layer Two Tunneling Protocol Version 2 (L2TPv2)
32. Erratum: Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning
33. Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
34. Response of Steroid-Refractory Acute GVHD to alpha1-Antitrypsin
35. Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up
36. Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
37. Are Intrauterine Insemination Pregnancy Rates Comparable between Ultrasound Monitoring and Home Ovulation Predictor Kits?
38. Five-year Follow up of Patients with Advanced Chronic Lymphocytic Leukemia Treated with Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning
39. Longer follow up of patients (PTS) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)
40. Relapse risk after nonmyeloablative hematopoietic cell transplantation for malignant diseases
41. Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates
42. A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation
43. Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
44. Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease
45. Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia
46. Does It Matter If You're Black or White: Relationship Between Race/Ethnicity and Fecundability in Intrauterine Insemination Cycles
47. Overlap Subtype of Chronic GVHD Is Associated with Adverse Prognosis, Functional Impairment, and Inferior Patient Reported Outcomes: A Chronic GVHD Consortium Study
48. Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)
49. A Randomized Phase III Trial Investigating 2 Gy TBI Vs. Flu/2 Gy TBI Conditioning for HLA-Matched Related Donor Hematopoietic Cell Transplantation (HCT): Tempo of CD3 and NK Cell Engraftment Determines Relapse and Progression Free Survival in Patients with Hematologic
50. Latent CMV and the CD4+ T Cell Transcription Program in Patients with Chronic GVHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.